IPO
IPO filing, visualized

Devonian Health Group Inc.

DHGR · NYSE AmericanCanadaF-1/A · Sep 2, 2026Filed

No price range yet · latest SEC filing Sep 2, 2026.

Pinch-zoom for details.

The offering

Shares offered
460,500
sold by the company

What the company does

Drug developer working on botanical (plant-based) medicines.

Revenue

Quarter

1st 9 months

Operating result

Quarter

1st 9 months

Net result

Quarter

1st 9 months

Things to weigh

  • Loss-making: net loss of CAD 5.74M in 9M 2026.

The numbers

CADQ 2025Q 2026Change9M 20259M 2026Change
Revenue7.36M177K−97.6%22.3M1.72M−92.3%
Operating result(34.7K)(1.94M)−5,499%(586K)(5.79M)−888%
Net result(4.80M)(1.94M)+59.6%(5.64M)(5.74M)−1.8%
CADQ 2025Q 2026Change
Revenue7.36M177K−97.6%
Operating result(34.7K)(1.94M)−5,499%
Net result(4.80M)(1.94M)+59.6%
CAD9M 20259M 2026Change
Revenue22.3M1.72M−92.3%
Operating result(586K)(5.79M)−888%
Net result(5.64M)(5.74M)−1.8%

Values as filed, shortened (K = thousand, M = million, B = billion); losses in parentheses. Change columns compare each period with the same period a year earlier; a bigger loss shows as a negative change. Green is better for the company, red worse; n/m where the sign flips.

Risks

The filing doesn't set out its risks in a list we could read.

Strategy

The filing doesn't set out its strategy in a list we could read.

Source: Devonian Health Group Inc.'s Form F-1/A, filed with the SEC on Sep 2, 2026 (preliminary prospectus). Figures are as filed; changes are worked out from them. Not investment advice.

10KDecoder10KDecoder.com

10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.